In ₹ Crore except Per Share 12 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|
| Other Income | 324.3 | 0.4 | 0.2 | 0.2 | 469.3 | 0.6 | |
| Revenue Detail — as filed | |||||||
| + Operating Income | 2,855.2 | 2,179.5 | 2,408.4 | 2,497.7 | 3,111.7 | 2,359.4 | |
| + Income from Investments (net) | 284.1 | 314.1 | 319.9 | 337.4 | 341.4 | 351.8 | |
| Expense Detail — as filed | |||||||
| + Employee Remuneration & Welfare | 56.5 | 89.9 | 91.5 | 95.2 | 91.6 | 99.1 | |
| + Commission (net) | 598.3 | 572.1 | 602.6 | 602.9 | 566.7 | 615.1 | |
| + Commission & Brokerage (net) | 598.3 | 572.1 | 602.6 | 602.9 | 566.7 | 615.1 | |
| + Non-operating Expense | 377.4 | 18.0 | 18.8 | 22.0 | 507.5 | 23.6 | |
| + Non-operating Provision — Doubtful Debts | 0.0 | 0.0 | 0.0 | 0.0 | 10.2 | 1.7 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | |||||||
| Profit before Extraordinary Items | 115.6 | 160.7 | 135.6 | 162.9 | 172.5 | 115.5 | |
| Profit / (Loss) before Tax — alt tag | 115.6 | 160.7 | 135.6 | 162.9 | 172.5 | 115.5 | |
| + Provision for Tax | 0.0 | 22.3 | 19.1 | 22.8 | 23.1 | 29.1 | |
| Profit / (Loss) after Tax | 115.6 | 138.3 | 116.5 | 140.1 | 149.4 | 86.4 | |
| Profit Carried to Balance Sheet | 115.6 | 138.3 | 116.5 | 140.1 | 149.4 | 86.4 | |
| Per Share — as-filed variants | |||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 1.25 | 1.50 | 1.26 | 1.52 | 1.62 | 0.93 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 1.25 | 1.49 | 1.26 | 1.51 | 1.61 | 0.93 | |
| Appropriations & Transfers | |||||||
| + Transfer to Profit & Loss Account | 429.1 | 120.9 | 74.0 | 111.6 | 611.0 | 70.4 | |
| Reserves & Surplus excl. Revaluation Reserve | 3,142.4 | 3,286.6 | 3,409.1 | 3,557.7 | 3,716.4 | 3,811.0 | |
| Insurance — Revenue Account (Policyholders') | |||||||
| Premium Earned | 2,246.9 | 1,865.0 | 2,088.2 | 2,160.1 | 2,301.0 | 2,007.0 | |
| + Gross Premiums Written | 2,576.4 | 2,981.8 | 2,667.5 | 2,909.2 | 2,735.7 | 2,730.9 | |
| + Net Premium Written | 2,033.8 | 1,950.6 | 2,109.3 | 2,148.2 | 2,113.2 | 2,094.2 | |
| + Operating Expenses — Insurance Business | 108.7 | 175.2 | 207.5 | 216.5 | 203.4 | 202.0 | |
| + Non-operating Expenses — Non-insurance | 377.4 | 18.0 | 18.8 | 22.0 | 497.3 | 21.8 | |
| + Claims Paid | 1,353.6 | 902.5 | 1,098.2 | 1,310.6 | 1,175.8 | 1,046.5 | |
| + Incurred Claims | 1,719.2 | 1,311.3 | 1,524.4 | 1,566.7 | 1,730.6 | 1,471.9 | |
| + Change in Outstanding Claims | 365.6 | 408.8 | 426.2 | 256.1 | 554.8 | 425.3 | |
| Insurance — Shareholders' Account | |||||||
| + Income — Shareholders' Account | 493.1 | 178.6 | 154.4 | 184.9 | 680.1 | 139.0 | |
| + Shareholders' Investment Income | 63.6 | 56.9 | 79.9 | 72.9 | 68.5 | 68.2 | |
| + Transfer from Policyholders' Fund | 429.1 | 120.9 | 74.0 | 111.6 | 611.0 | 70.4 | |
| With Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | |||||||
| Solvency Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 2.42 | 0.02 | |
| Combined Ratio | 1.11 | 1.09 | 1.11 | 1.11 | 1.12 | 1.12 | |
| Incurred Claim Ratio | 0.77 | 0.70 | 0.73 | 0.73 | 0.75 | 0.73 | |
| Net Retention Ratio | 0.79 | 0.65 | 0.79 | 0.74 | 0.77 | 0.77 | |
| Expenses of Management Ratio | 0.39 | 0.35 | 0.42 | 0.43 | 0.42 | 0.39 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||
| Investor Complaints — Received | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| Investor Complaints — Disposed | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| Related-party Transactions — During the Period | 22.2 | — | 10.3 | — | 70.8 | — | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||
| Operating Expenses | 2,426.1 | 2,058.6 | 2,334.4 | 2,386.1 | 2,500.8 | 2,289.0 | |
| Other Operating Expenses | 52.2 | 85.2 | 116.0 | 121.3 | 111.8 | 102.9 | |